510(k) K822607

ANTINUCLEAR ANTOBODY CELL SUBSTRATE by Immulok, Inc. — Product Code DHN

K822607 is an FDA 510(k) premarket notification submitted by Immulok, Inc. for the device "ANTINUCLEAR ANTOBODY CELL SUBSTRATE". The FDA issued a decision of Substantially Equivalent on Sep 17, 1982. The device falls under product code DHN (Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control), a Class II device regulated under 21 CFR 866.5100. Immulok, Inc. has 14 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Sep 17, 1982
Date Received
Aug 27, 1982
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control
Device Class
Class II
Regulation Number
866.5100
Review Panel
IM
Submission Type
510(k)

Need the full FDA record for Immulok, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K822607. Report a data issue: hello@regdatalab.com.